Bigul

Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Investor Presentation

Submission of Investor presentation on Audited Financial Results for the quarter and year ended March 31, 2024.
29-05-2024
Bigul

Entero Healthcare Solutions Ltd - 544122 - Audited Standalone & Consolidated Financial Results For The Quarter And Year Ended March 31, 2024

Audited Standalone & Consolidated Financial Results for the Quarter and Year ended March 31, 2024
29-05-2024
Bigul

Entero Healthcare Solutions Ltd - 544122 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Annual Secretarial Compliance Report for the financial year ended March 31, 2024
29-05-2024
Bigul

Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Intimation of Earnings call on audited financial results for the Quarter and Year ended March 31, 2024.
24-05-2024
Bigul

Entero Healthcare Solutions Ltd - 544122 - Board Meeting Intimation for Approval Of Audited Financial Results Of The Company For The Quarter And Year Ended March 31, 2024

Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 ,inter alia, to consider and approve Audited Financial Results of the Company for the quarter and year ended March 31, 2024
22-05-2024
Bigul

Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

Submission of Monitoring Agency Report issued by ICRA Limited for the quarter ended March 31, 2024
15-05-2024
Bigul

Entero Healthcare Solutions Ltd - 544122 - Announcement under Regulation 30 (LODR)-Acquisition

The Board of Directors of Entero Healthcare Solutions Limited ("Company") has approved, inter-alia, to execute the definitive agreement to acquire 80% paid up equity capital share capital of Avenir Lifecare Pharma Private Limited (ALPPL) at their meeting held on May 06, 2024.
06-05-2024
Next Page
Close

Let's Open Free Demat Account